Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin type A plus rehabilitation for post-stroke upper limb spasticity
ChiCTR2600131405Phase 4Not yet recruiting
- Sponsor
- Meizhou People's Hospital
- Start
- Jun 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of botulinum toxin type A in stroke (2 arms), sponsored by Meizhou People's Hospital. Primary endpoint: Muscle tone. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
stroke
Beyond the preview
Go deeper on ChiCTR2600131405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600131405.